
Vir Biotechnology Inc
NASDAQ:VIR

Relative Value
The Relative Value of one
VIR
stock under the Base Case scenario is
1.72
USD.
Compared to the current market price of 5.4 USD,
Vir Biotechnology Inc
is
Overvalued by 68%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
